Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „avoid“
Suchtreffer
Begriffe & Kennungen
Triumeq · 4.5 · Sorbitol Sorbitol solution (3.2 g, 10.2 g, Single dose lamivudine When possible, avoid chronic 13.4 g)/Lamivud
Eintrag öffnenTrizivir · 4.5 · 11 Sorbitol solution (3.2 g, 10.2 g, Single dose lamivudine oral When possible, avoid chronic 13.4 g)/ Lamivud
Eintrag öffnenTruvada · 4.5 · Use of Truvada should be avoided with concurrent or recent use of a nephrotoxic medicinal product. Some exampl
Eintrag öffnenVenclyxto · 4.5 · Grapefruit products, Seville oranges, and starfruit (carambola) should be avoided during treatment with veneto
Eintrag öffnenVermeidende restriktive Essstörung
Eintrag öffnenVermeidungslernen
Eintrag öffnenVerzenios · 4.5 · Use of strong CYP3A4 inhibitors together with abemaciclib should be avoided. If strong CYP3A4 inhibitors need
Eintrag öffnenVfend · 4.5 · 42 Rifabutin Concomitant use of voriconazole [potent CYP450 inducer] and rifabutin should be avoided Voriconaz
Eintrag öffnenViread · 4.5 · Use of tenofovir disoproxil should be avoided with concurrent or recent use of a nephrotoxic medicinal product
Eintrag öffnenViread · 4.5 · Use of tenofovir disoproxil should be avoided with concurrent or recent use of a nephrotoxic medicinal product
Eintrag öffnenViread · 4.5 · Use of tenofovir disoproxil should be avoided with concurrent or recent use of a nephrotoxic medicinal product
Eintrag öffnenViread · 4.5 · Use of tenofovir disoproxil should be avoided with concurrent or recent use of a nephrotoxic medicinal product
Eintrag öffnenViread · 4.5 · Use of tenofovir disoproxil should be avoided with concurrent or recent use of a nephrotoxic medicinal product
Eintrag öffnenVoriconazole Hikma (previously Voriconazole Hospira) · 4.5 · 11 Rifabutin Concomitant use of voriconazole [potent CYP450 inducer] and rifabutin should be avoided Voriconaz
Eintrag öffnenVotrient · 4.5 · Combination with strong P-gp or BCRP inhibitors should be avoided, or selection of an alternate concomitant me
Eintrag öffnenVotrient · 4.5 · Concomitant use of pazopanib with a strong CYP3A4 inhibitor should be avoided (see section 4.4). If no medical
Eintrag öffnenVotubia · 4.5 · 38 Potent and moderate CYP3A4 inducers Rifampicin AUC ↓63% Avoid the use of concomitant potent (range 0-80%) C
Eintrag öffnenWayrilz · 4.5 · Avoid co-administration of grapefruit, starfruit and products containing these fruits, and Seville oranges wit
Eintrag öffnenWayrilz · 4.5 · Avoid co-administration of moderate or strong CYP3A inhibitors (e.g., ritonavir, clarithromycin, itraconazole,
Eintrag öffnenWayrilz · 4.5 · Avoid co-administration of rilzabrutinib with PPIs. If treatment with a gastric acid reducing agent is require
Eintrag öffnen